6261 - 6270 of 8825 Results
Title
Year
-
OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 26
-
OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 14
-
OPENTitle: Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brainJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.67900Best OA location URL: https://doi.org/10.7554/elife.67900Citation Count: 102
-
OPENTitle: Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brainJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 7End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00509-5Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-021-00509-5Citation Count: 62
-
OPENTitle: Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s DiseaseJournal Name: DiagnosticsPublisher: MDPI AGVol: 11Issue #: 12Start Page: 2303End Page: 2303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics11122303Best OA location URL: https://www.mdpi.com/2075-4418/11/12/2303/pdf?version=1638953319Citation Count: 14
-
OPENTitle: Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk PredictivityJournal Name: Frontiers in GeneticsPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 785436End Page: 785436Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fgene.2021.785436Best OA location URL: https://doi.org/10.3389/fgene.2021.785436Citation Count: 10
-
OPENTitle: Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasisJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 2Start Page: e105531End Page: e105531Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.2020105531Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8762563Citation Count: 28
-
OPENTitle: Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegenerationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 12Start Page: 3674End Page: 3691Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab356Best OA location URL: https://academic.oup.com/brain/article-pdf/144/12/3674/42004692/awab356.pdfCitation Count: 26
-
OPENTitle: Trajectory Analysis of Orthostatic Hypotension in Parkinson’s Disease: Results From Parkinson’s Progression Markers Initiative CohortJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 762759End Page: 762759Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.762759Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.762759/pdfCitation Count: 10
-
OPENTitle: Safety of AADC Gene Therapy for Moderately Advanced Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 1Start Page: e40End Page: e50Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000012952Best OA location URL: https://escholarship.org/uc/item/9jh0j4gbCitation Count: 77